-transparent.png){kind=logo}
The ability of arginine vasopressin (AVP) to potentiate the actions of synthetic ovine corticotropin-releasing factor (CRF) was examined using anterior pituitary fragments. Marked potentiation of ACTH release was observed upon incubating the fragments with a combination of 2 nM AVP and 1 nM CRF. Potentiation of CRF-induced ACTH release was also observed when the fragments were incubated with a combination of 1 nM AVP and 0.5 nM CRF. These results suggest that AVP may play a role in the release of ACTH from the adenohypophysis.
Related Publications
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
February 1984,
The Journal of clinical investigation,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
July 1984,
Neuroendocrinology,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
September 1984,
Life sciences,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
January 1971,
Endocrinology,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
September 1982,
Experientia,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
November 1990,
Endocrinology,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
May 1984,
Neuroendocrinology,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
November 1983,
The Journal of clinical endocrinology and metabolism,
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
July 1961,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
C M Turkelson, and
C R Thomas, and
A Arimura, and
D Chang, and
J K Chang, and
M Shimizu
January 1985,
Federation proceedings,
